US Stock MarketDetailed Quotes

IRD Opus Genetics

Watchlist
  • 0.979
  • -0.009-0.87%
Close Dec 20 16:00 ET
  • 1.060
  • +0.081+8.32%
Post 20:01 ET
30.89MMarket Cap-0.90P/E (TTM)

Opus Genetics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Opus Genetics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 2.000M--
--2024/Q4-- / 11.104M--
--2024/Q33.867M / 2.296M--
--2024/Q21.112M / 1.942M--
--2024/Q11.711M / 4.670M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 2.000M--
--2024/Q4-- / 11.104M--
--2024/Q33.867M / 2.296M--
--2024/Q21.112M / 1.942M--
--2024/Q11.711M / 4.670M--

Unlock Free Earnings Estimates

Opus Genetics Earnings Reports

  • Opus Genetics | 8-K: Opus Genetics Announces Financial Results for Third Quarter 2024 and Provides Corporate Update

    Nov 12 22:42

  • Opus Genetics | 10-Q: Q3 2024 Earnings Report

    Nov 12 22:40

  • Ocuphire Pharma | 10-Q: Q2 2024 Earnings Report

    Aug 14 04:12

  • Ocuphire Pharma | 8-K: Ocuphire Pharma Announces Financial Results for Second Quarter 2024 and Provides Corporate Update

    Aug 13 20:17

    • Read more

    Analysis

    Analyst Rating

    Updated: Dec 15, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data